FTE Hours. Sections 6.5.1 and 7.1.5 of the Agreement will apply to the Amendment-Additional Collaboration Target in the same manner as applied to each Oncology Product, except the reference in those Sections to [***]. Instead, under each of Sections 6.5.1 and 7.1.5 of the Agreement up to [***] of Isis’ time shall be available [***] to AstraZeneca (being [***] in total) specifically in respect of the Amendment-Additional Collaboration Target.
Appears in 2 contracts
Sources: Collaboration, License and Development Agreement (Ionis Pharmaceuticals Inc), Collaboration, License and Development Agreement (Isis Pharmaceuticals Inc)